<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Pain Med</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Pain Med</journal-id><journal-id journal-id-type="doi">10.5812/aapm</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Anesthesiology and Pain Medicine</journal-title></journal-title-group><issn pub-type="ppub">2228-7523</issn><issn pub-type="epub">2228-7531</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24223345</article-id><article-id pub-id-type="pmc">3821122</article-id><article-id pub-id-type="doi">10.5812/aapm.6884</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of Remifentanil and Fentanyl Regarding Hemodynamic Changes Due to Endotracheal Intubation in Preeclamptic Parturient Candidate for Cesarean Delivery</article-title><alt-title alt-title-type="short">Remifentanil, Fentanyl: Hemodynamic Markers in Preeclamptic Parturient</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pournajafian</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="aff6978">1</xref><xref ref-type="corresp" rid="cor6978">*</xref></contrib><contrib contrib-type="author"><name><surname>Rokhtabnak</surname><given-names>Faranak</given-names></name><xref ref-type="aff" rid="aff6978">1</xref></contrib><contrib contrib-type="author"><name><surname>Kholdbarin</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="aff6978">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghodrati</surname><given-names>Mohammadreza</given-names></name><xref ref-type="aff" rid="aff6978">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghavam</surname><given-names>Siamak</given-names></name><xref ref-type="aff" rid="aff6978">1</xref></contrib></contrib-group><aff id="aff6978"><label>1</label>Department of Anesthesiology, Firoozgar Hospital, Iran University of Medical Sciences (IUMS), Tehran, IR Iran </aff><author-notes><corresp id="cor6978"><label>*</label>Corresponding author: Alireza Pournajafian, Department of Anesthesiology, Firoozgar Hospital, Beh Afarin St., Karim Khan Blvd. Tehran, IR Iran. Tel.: +98-2188946762, Fax: +98-2188942622, E-mail: <email>a-pournajafian@tums.ac.ir</email>.</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>9</month><year>2012</year></pub-date><pub-date pub-type="ppub"><season>Autumn</season><year>2012</year></pub-date><volume>2</volume><issue>2</issue><fpage>90</fpage><lpage>93</lpage><history><date date-type="received"><day>20</day><month>6</month><year>2012</year></date><date date-type="rev-recd"><day>05</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>25</day><month>7</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012, Iranian Society of Regional Anesthesia and Pain Medicine</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Intravenous opioids are administered to prevent and control hemodynamic changes due to endotracheal intubation. Except for special cases such as preeclampsia, these drugs are not recommended for parturants candidate for cesarean section because of the respiratory depression caused in the newborn.</p></sec><sec><title>Objectives</title><p>According to rapid metabolism of remifentanil, the current study aimed to compare hemodynamic changes in preeclamptic parturants who received remifentanil and fentanyl for cesarean section under general anesthesia.</p></sec><sec><title>Patients and Methods</title><p>This single blind randomized clinical trial was performed on preeclamptic pregnant women candidate for cesarean section under general anesthesia. They were divided into two groups. In the first group 0.05 &#x003bc;g/kg/min remifentanil was infused for 3 minutes before induction of anesthesia and in the second group 1ml (50 &#x003bc;g) fentanyl was injected before induction. Heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) before and after intubation and also Apgar index were measured and compared between the two groups.</p></sec><sec><title>Results</title><p>All hemodynamic variables increased after intubation in the fentanyl group (pSBP = 0.146, pDBP = 0.019, pHR &#x0003c; 0.001). Additionally, decrease in SBP (P = 0.018) and DBP (P = 0.955) and mild increase in HR (P = 0.069) after intubation in the remifentanil group was observed. No significant difference was found between Apgar indexes of the two groups (P = 0.771).</p></sec><sec><title>Conclusions</title><p>It can be postulated that remifentanil can be used in partituents candidate for cesarean delivery under general anesthesia to prevent severe increase in blood pressure and heart rate during tracheal intubation without adverse effects on newborn.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Cesarean Section</kwd><kwd>Pre-Eclampsia</kwd><kwd>Intubation, Intratracheal</kwd><kwd>Fentanyl</kwd><kwd>Remifentanil</kwd></kwd-group></article-meta></front><body><sec id="sec564"><title>1. Background</title><p>During general anesthesia, endotracheal intubation (ETI) results in stimulation of sympathetic nervous system and catecholamine release and therefore, increase in blood pressure, heart rate (HR) and heart load (<xref ref-type="bibr" rid="A6884R1">1</xref>). Thus, opioids have been used to minimize these responses to short-term stimuli such as ETI in the setting of pediatrics and obstetrics as well as other situations (<xref ref-type="bibr" rid="A6884R2">2</xref>, <xref ref-type="bibr" rid="A6884R3">3</xref>). Opioid administration is not recommended in general anesthesia in parturients for cesarean section, because of its depressant effects on newborn. In preeclampsia, however, the sympathetic-suppressing role of opioids seems to be crucial because ETI hypertension already exists and moreover, the ETI-induced catecholamine secretion can result in fetal arrhythmia and intracranial hemorrhage. Apart from that, opioids can decrease fetal perfusion due to their suppressive impact over circulatory system by exacerbation of aortocaval compression (<xref ref-type="bibr" rid="A6884R4">4</xref>). Small doses of fentanyl are acceptable in preeclamptic parturients without adverse effects on newborn (<xref ref-type="bibr" rid="A6884R5">5</xref>, <xref ref-type="bibr" rid="A6884R6">6</xref>). Therefore, an agent of short onset and offset of effects such as remifentanil seems to be of great advantage. Remifentanil has unique properties especially in pharmacokinetics which alters negligibly in liver or kidney disorders and age variations. Moreover, its rapid dissipation is a prominent privilege (<xref ref-type="bibr" rid="A6884R7">7</xref>, <xref ref-type="bibr" rid="A6884R8">8</xref>).</p></sec><sec id="sec565"><title>2. Objectives</title><p>The current study aimed to evaluate hemodynamic changes induced by ETI if remifentanil is used compared to fentanyl. The research was carried out for the first time in the setting of cesarean delivery in preeclamptic patients.</p></sec><sec id="sec566"><title>3. Patients and Methods</title><p>This randomized trial was carried out in Tehran University of Medical Sciences, department of Anesthesia in Firoozgar hospital, Tehran, Iran. The study was approved by the institutional committee of ethics in Tehran University of Medical Science (No: 4276) and was registered to Iranian Registry of Clinical Trials (Irct ID: IRCT201108294969N2). Written and informed consent was obtained from all patients as well. Patients within the range of 18-45 diagnosed with preeclampsia and candidate for cesarean delivery were considered as subjects of the study. Patients presenting with cardiopulmonary disorders, hyper- or hypothyroidism, history of opioid and/or alcohol misuse, drug history of sedatives, benzodiazepines, alpha and/or beta agonists, beta antagonists and patients with complicated ETI history were excluded from the study. After allocating the patients (by block randomization) into two groups, their heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded via noninvasive technique (by &#x0201c;ALBORZ B5&#x0201d; monitor made by &#x0201c;Pooyandegan Rah Saadat&#x0201d; Co., Tehran, Iran); also, pulse oximetry was performed in supine position as well. All patients received 500ml intravenous normal saline and were preoxygenated by 6 liters per minute flow of 100% oxygen for five minutes. Thereafter, patients in group one received 50 &#x003bc;g fentanyl (bolus dose), and patients in group two received remifentanil infusion at 0.05 &#x003bc;g/kg/min for three minutes before induction and continued until intubation time. Afterward, rapid sequence induction of anesthesia was commenced with sodium thiopental at 5 mg/kg and then succinylcholine at 1.5 mg/kg (three minutes after fentanyl injection and beginning remifentanil infusion). After cricoid pressure and 60 seconds from the latest injection, ETI was performed and all patients were mechanically ventilated (tidal volume of 10 ml/kg). Maintenance of anesthesia was provided by 0.5% Halothane + 50% N2O in oxygen. The variables of HR, SBP and DBP were recorded before ETI and immediately after that and checking the right place of tube. Apgar index was calculated for each neonate at the 1st minute after delivery. SPSS software Version 11 was employed to perform chi-square and Pair t-tests for statistical analysis.</p></sec><sec id="sec567"><title>4. Results</title><p>47 patients were enrolled into the study, but 43 were allocated randomly in two group. Two patients in remifentanil group and three in the other were excluded because of difficulties in tracheal intubation and need to more attempts to secure airway and ventilation. Out of remaining 38 patients, 20 and 18 were studied in remifentanil and fentanyl groups respectively. Mean age of patients was 29.14 and 28.91 years, respectively (P &#x0003e; 0.05). Mean of gestational age of parturients in remifentanil group was 30.11 weeks and in fentanyl group was 29.78 weeks (P = 0.12). Mean of total dose of fentanyl used in the second group was 0.735 &#x003bc;g/kg. <xref ref-type="table" rid="tbl168">Table 1</xref> summarizes the mean values of HR, SBP and DBP in remifentanil and fentanyl groups before and after ETI. These variables had increased in level after ETI in fentanyl group. Of the three variables, HR and DBP demonstrated significant difference (P &#x0003c; 0.001 and 0.019, respectively). In remifentanil group, however, apart from HR that increased after ETI, SBP and DBP decreased but only differences of the SBP was significant (P = 0.018). This suggests the priority of remifentanil over fentanyl in the patients. <xref ref-type="table" rid="tbl169">Table 2</xref> indicates that there was no significant difference between mean Apgar indexes of neonates in the two groups. The minimum Apgar recorded in both group was 7. The number of neonates with apgar score 7, 8, 9, 10 in remifentanil group were 1, 6, 9, 4 and in Fentanyl group were 1, 7, 7, 3 respectively. No newborn in both groups needed tracheal intubation or ventilatory support.</p><table-wrap id="tbl168" orientation="portrait" position="float"><label>Table 1</label><caption><title>Comparison Between Remifentanil and Fentanyl Groups Regarding Hemodynamic Markers</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th colspan="2" align="center" style="border-bottom: solid thin" rowspan="1">Remifentanil Group</th><th colspan="2" align="center" style="border-bottom: solid thin" rowspan="1">Fentanyl Group</th></tr><tr><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Mean</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> value</th><th align="left" rowspan="1" colspan="1">Mean</th><th align="left" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>HR</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.069</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">Before ETI</td><td rowspan="1" colspan="1">86.85 &#x000b1; 2.482</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">85.17 &#x000b1; 3.208</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">After ETI</td><td rowspan="1" colspan="1">89.20 &#x000b1; 2.676</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">91.94 &#x000b1; 2.982</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>SBP </bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.018</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.146</td></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">Before ETI</td><td rowspan="1" colspan="1">154.35 &#x000b1; 5.262</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">149.50 &#x000b1; 3.764</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">After ETI</td><td rowspan="1" colspan="1">148.35 &#x000b1; 4.736</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">153.11 &#x000b1; 4.213</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>DBP </bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.955</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.019</td></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">Before ETI</td><td rowspan="1" colspan="1">88.55 &#x000b1; 3.226</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">87.61 &#x000b1; 2.707</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left:25pt;" rowspan="1" colspan="1">After ETI</td><td rowspan="1" colspan="1">88.40 &#x000b1; 2.374</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">92.22 &#x000b1; 2.644</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="fn105"><p><sup>Abbreviations:</sup>ETI, endotracheal intubation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl169" orientation="portrait" position="float"><label>Table 2</label><caption><title>Comparison Between Remifentanil and Fentanyl Groups Regarding Apgar Index in Neonates 1min After delivery</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
&#x0003e;Apgar Index
</th><th align="left" rowspan="1" colspan="1">
No. (Mean &#x000b1; SD)
</th><th align="left" rowspan="1" colspan="1">
<italic>P</italic> value
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
Remifentanil group
</td><td rowspan="1" colspan="1">
20 (0.880 &#x000b1; 0.083)
</td><td rowspan="1" colspan="1">
0.771
</td></tr><tr><td rowspan="1" colspan="1">
Fentanyl group
</td><td rowspan="1" colspan="1">
18 (0.866 &#x000b1; 0.084)
</td><td rowspan="1" colspan="1">
0.771
</td></tr></tbody></table></table-wrap></sec><sec id="sec568"><title>5. Discussion</title><p>Remifentanil is known as an ultrashort effect opioid which has a half-life of 1.3 minute. This drug has a higher clearance rate than liver blood flow and significant extra-hepatic metabolism and trivial pulmonary metabolism (<xref ref-type="bibr" rid="A6884R9">9</xref>). Additionally, its concentration ratio between umbilical vein and umbilical artery is 0.88 which does not result in remarkable fetal exposure due to its rapid metabolism (<xref ref-type="bibr" rid="A6884R10">10</xref>). The current study attempted to compare hemodynamic changes in preeclamptic parturients at cesarean delivery after ETI and administration of remifentanil vs. fentanyl. No severe changes were observed in hemodynamic markers of mothers but superiority of remifentanil over fentanyl can be suggested. This is because of significant decrease in SBP in remifentanil group vs. significant increase in HR and DBP in fentanyl group, both after ETI.</p><p>Safety and efficacy of remifentanil have been demonstrated in some case series and randomized controlled trials (RCTs) in pregnant women. Roelants et al. used 0.05 &#x000b5;g/kg per minute infusion and 25 &#x003bc;g bolus of remifentanil and observed 5 minutes analgesia during normal vaginal delivery (<xref ref-type="bibr" rid="A6884R11">11</xref>). Moreover, it has been reported by Owen et al. that 34 hours of remifentanil infusion has no noticeable adverse effect on newborn (<xref ref-type="bibr" rid="A6884R12">12</xref>). Furthermore, in the study conducted by Douma et al., superiority of remifentanil over fentanyl and meperidine in labor was provided. This had reduced the need for regional anesthetic support while no change in Apgar index was observed (<xref ref-type="bibr" rid="A6884R13">13</xref>). Palacio et al. also showed no negative impact upon neonates born from parturients with obstetric emergencies when remifentanil bolus dose at 1&#x003bc;g/kg was administered as maintenance in cesarean sections (<xref ref-type="bibr" rid="A6884R14">14</xref>). Although routinely opioids are not drugs of choice in induction of general anesthesia during cesarean section, little amounts of fentanyl is administered in cases with preeclampsia, HELLP syndrome, coagulopathies and patient&#x02019;s refusal of spinal anesthesia (<xref ref-type="bibr" rid="A6884R15">15</xref>, <xref ref-type="bibr" rid="A6884R16">16</xref>). In such cases, however, hemodynamic responses to ETI are unavoidable. Because of transient delayed respiratory depression with higher doses of remifentanil was noted in some newborns (<xref ref-type="bibr" rid="A6884R17">17</xref>-<xref ref-type="bibr" rid="A6884R20">20</xref>), in the current study safe dose of this drug that had been previously used in labor, was considered. Opioids was also used in epidural space in pregnant women for cesarean section without significant difference in maternal complications and Apgar scores (<xref ref-type="bibr" rid="A6884R21">21</xref>). Safavi M et al. showed that some drugs such as Nitroglycerin are effective in attenuating the pressor response to tracheal intubation in severe preeclampsia and could be used instead of opioids to control hemodynamic responses (<xref ref-type="bibr" rid="A6884R22">22</xref>). Remifentanil and fentanyl were also used effectively in endotracheal intubation without use of neuromuscular blocking drugs (<xref ref-type="bibr" rid="A6884R23">23</xref>, <xref ref-type="bibr" rid="A6884R24">24</xref>). Remifentanil infusion tends to faster wake up test than alfentanil in spinal fusion surgeries (<xref ref-type="bibr" rid="A6884R25">25</xref>) (because of rapid metabolism) and is suggested to be used in situations that require fast effect and rapid recovery of opioid effects. In this regard, it was postulated that remifentanil may perform a prominent role because of its stabilizing impact on heart rate, blood pressure and Apgar index. Low dose remifentanil can be used safely in parturients candidate for cesarean section without noticeable adverse effects on newborn.</p></sec></body><back><ack><p>We would like to appreciate all anesthesia technicians in operating room of Firoozgar hospital who helped us in this project.</p></ack><fn-group><fn id="afn397" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold> Opioids are useful in minimizing sympathetic responses after endotracheal intubation. Administration of these drugs is not recommended in pregnant women candidate for cesarean section, due to their depressant effects on newborn, but in special conditions such as preeclampsia, low doses of fentanyl could be used without maternal or newborn side effects. Remifentanil, an opioid with rapid onset and fast metabolism can be a good alternative for other drugs in these situations.</p></fn><fn id="afn398" fn-type="other"><p><bold>Please cite this paper as:</bold> Pournajafian A, Rokhtabnak F, Kholdbarin A, Ghodrati M, Ghavam S. Comparison of Remifentanil and Fentanyl Regarding Hemodynamic Changes Due to Endotracheal Intubation in Preeclamptic Parturient Candidate for Cesarean Delivery. Anesth Pain. 2012;2(2):90-3. DOI: 10.5812/aapm.6884</p></fn><fn id="afn399" fn-type="other"><p><bold>Authors&#x02019; Contribution:</bold> None declared.</p></fn><fn id="afn400" fn-type="financial-disclosure"><p><bold>Financial Disclosure:</bold> None declared.</p></fn><fn id="afn401" fn-type="other"><p><bold>Funding/Support:</bold> Tehran University of Medical Science.</p></fn></fn-group><ref-list><title>References</title><ref id="A6884R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shribman</surname><given-names>AJ</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Achola</surname><given-names>KJ</given-names></name></person-group><article-title>Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation.</article-title><source>Br J Anaesth.</source><year>1987</year><volume>59</volume><issue>3</issue><fpage>295</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/bja/59.3.295</pub-id><pub-id pub-id-type="pmid">3828177</pub-id></element-citation></ref><ref id="A6884R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cafiero</surname><given-names>T</given-names></name><name><surname>Di Minno</surname><given-names>RM</given-names></name><name><surname>Di Iorio</surname><given-names>C</given-names></name></person-group><article-title>QT interval and QT dispersion during the induction of anesthesia and tracheal intubation: a comparison of remifentanil and fentanyl.</article-title><source>Minerva Anestesiol.</source><year>2011</year><volume>77</volume><issue>2</issue><fpage>160</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21150850</pub-id></element-citation></ref><ref id="A6884R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safavi</surname><given-names>M</given-names></name><name><surname>Honarmand</surname><given-names>A</given-names></name></person-group><article-title>Attenuation of cardiovascular responses to laryngoscopy and tracheal intubation--intravenous sufentanil vs pethidine.</article-title><source>Middle East J Anesthesiol.</source><year>2008</year><volume>19</volume><issue>6</issue><fpage>1349</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18942248</pub-id></element-citation></ref><ref id="A6884R4"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kazuhiko</surname><given-names>F</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Miller</surname><given-names>RD</given-names></name><name><surname>Eriksson</surname><given-names>LI</given-names></name><name><surname>Fleisher</surname><given-names>LA</given-names></name><name><surname>Wiener-Kronish</surname><given-names>JP</given-names></name><name><surname>Young</surname><given-names>WL</given-names></name></person-group><year>2009</year><article-title>Anesthesia E-Book: 2-Volume Set: Opioids.</article-title><publisher-name>Elsevier Health Sciences</publisher-name></element-citation></ref><ref id="A6884R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisele</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>R</given-names></name><name><surname>Rogge</surname><given-names>P</given-names></name></person-group><article-title>Newborn and maternal fentanyl levels at cesarean section.</article-title><source>Anesth Analg.</source><year>1982</year><volume>61</volume><issue>2</issue><fpage>179</fpage></element-citation></ref><ref id="A6884R6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Glosten</surname><given-names>B</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Miller</surname><given-names>RD</given-names></name><etal>et al</etal></person-group><article-title>Anesthesia for obstetrics.</article-title><source>Clinical Anesthesia.</source><edition>5th edition</edition><year>2000</year></element-citation></ref><ref id="A6884R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>SP</given-names></name><name><surname>Egan</surname><given-names>TD</given-names></name></person-group><article-title>The safety of remifentanil by bolus injection.</article-title><source>Expert Opin Drug Saf.</source><year>2005</year><volume>4</volume><issue>4</issue><fpage>643</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1517/14740338.4.4.643</pub-id><pub-id pub-id-type="pmid">16011444</pub-id></element-citation></ref><ref id="A6884R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Servin</surname><given-names>FS</given-names></name><name><surname>Billard</surname><given-names>V</given-names></name></person-group><article-title>Remifentanil and other opioids.</article-title><source>Handb Exp Pharmacol.</source><year>2008</year><issue>182</issue><fpage>283</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">18175097</pub-id></element-citation></ref><ref id="A6884R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>PS</given-names></name><name><surname>Hardman</surname><given-names>D</given-names></name><name><surname>Kamiyama</surname><given-names>Y</given-names></name><name><surname>Quill</surname><given-names>TJ</given-names></name><name><surname>Marton</surname><given-names>G</given-names></name><name><surname>Donn</surname><given-names>KH</given-names></name><etal>et al.</etal></person-group><article-title>Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).</article-title><source>Anesth Analg.</source><year>1993</year><volume>77</volume><issue>5</issue><fpage>1031</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1213/00000539-199311000-00028</pub-id><pub-id pub-id-type="pmid">8105723</pub-id></element-citation></ref><ref id="A6884R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kan</surname><given-names>RE</given-names></name><name><surname>Hughes</surname><given-names>SC</given-names></name><name><surname>Rosen</surname><given-names>MA</given-names></name><name><surname>Kessin</surname><given-names>C</given-names></name><name><surname>Preston</surname><given-names>PG</given-names></name><name><surname>Lobo</surname><given-names>EP</given-names></name></person-group><article-title>Intravenous remifentanil: placental transfer, maternal and neonatal effects.</article-title><source>Anesthesiology.</source><year>1998</year><volume>88</volume><issue>6</issue><fpage>1467</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1097/00000542-199806000-00008</pub-id><pub-id pub-id-type="pmid">9637638</pub-id></element-citation></ref><ref id="A6884R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roelants</surname><given-names>F</given-names></name><name><surname>De Franceschi</surname><given-names>E</given-names></name><name><surname>Veyckemans</surname><given-names>F</given-names></name><name><surname>Lavand&#x02019;homme</surname><given-names>P</given-names></name></person-group><article-title>Patient-controlled intravenous analgesia using remifentanil in the parturient.</article-title><source>Can J Anaesth.</source><year>2001</year><volume>48</volume><issue>2</issue><fpage>175</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/BF03019731</pub-id><pub-id pub-id-type="pmid">11220427</pub-id></element-citation></ref><ref id="A6884R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>MD</given-names></name><name><surname>Poss</surname><given-names>MJ</given-names></name><name><surname>Dean</surname><given-names>LS</given-names></name><name><surname>Harper</surname><given-names>MA</given-names></name></person-group><article-title>Prolonged intravenous remifentanil infusion for labor analgesia.</article-title><source>Anesth Analg.</source><year>2002</year><volume>94</volume><issue>4</issue><fpage>918</fpage><lpage>9</lpage><comment>table of contents.</comment><pub-id pub-id-type="pmid">11916797</pub-id></element-citation></ref><ref id="A6884R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douma</surname><given-names>MR</given-names></name><name><surname>Verwey</surname><given-names>RA</given-names></name><name><surname>Kam-Endtz</surname><given-names>CE</given-names></name><name><surname>van der Linden</surname><given-names>PD</given-names></name><name><surname>Stienstra</surname><given-names>R</given-names></name></person-group><article-title>Obstetric analgesia: a comparison of patient-controlled meperidine, remifentanil, and fentanyl in labour.</article-title><source>Br J Anaesth.</source><year>2010</year><volume>104</volume><issue>2</issue><fpage>209</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1093/bja/aep359</pub-id><pub-id pub-id-type="pmid">20008859</pub-id></element-citation></ref><ref id="A6884R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacio</surname><given-names>FJ</given-names></name><name><surname>Ortiz-Gomez</surname><given-names>JR</given-names></name><name><surname>Fornet</surname><given-names>I</given-names></name><name><surname>Lopez</surname><given-names>MA</given-names></name><name><surname>Morillas</surname><given-names>P</given-names></name></person-group><article-title>[Remifentanil bolus for cesarean section in high-risk patients: study of 12 cases].</article-title><source>Rev Esp Anestesiol Reanim.</source><year>2008</year><volume>55</volume><issue>2</issue><fpage>86</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18383970</pub-id></element-citation></ref><ref id="A6884R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinova</surname><given-names>A</given-names></name><name><surname>Fernando</surname><given-names>R</given-names></name></person-group><article-title>Systemic remifentanil for labor analgesia.</article-title><source>Anesth Analg.</source><year>2009</year><volume>109</volume><issue>6</issue><fpage>1925</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e3181c03e0c</pub-id><pub-id pub-id-type="pmid">19923522</pub-id></element-citation></ref><ref id="A6884R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandya</surname><given-names>ST</given-names></name></person-group><article-title>Labour analgesia: Recent advances.</article-title><source>Indian J Anaesth.</source><year>2010</year><volume>54</volume><issue>5</issue><fpage>400</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.4103/0019-5049.71033</pub-id><pub-id pub-id-type="pmid">21189877</pub-id></element-citation></ref><ref id="A6884R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouattour</surname><given-names>L</given-names></name><name><surname>Ben Amar</surname><given-names>H</given-names></name><name><surname>Bouali</surname><given-names>Y</given-names></name><name><surname>Kolsi</surname><given-names>K</given-names></name><name><surname>Gargouri</surname><given-names>A</given-names></name><name><surname>Khemakhem</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>[Maternal and neonatal effects of remifentanil for general anaesthesia for Caesarean delivery].</article-title><source>Ann Fr Anesth Reanim.</source><year>2007</year><volume>26</volume><issue>4</issue><fpage>299</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.annfar.2007.01.005</pub-id><pub-id pub-id-type="pmid">17398061</pub-id></element-citation></ref><ref id="A6884R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draisci</surname><given-names>G</given-names></name><name><surname>Valente</surname><given-names>A</given-names></name><name><surname>Suppa</surname><given-names>E</given-names></name><name><surname>Frassanito</surname><given-names>L</given-names></name><name><surname>Pinto</surname><given-names>R</given-names></name><name><surname>Meo</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial.</article-title><source>Int J Obstet Anesth.</source><year>2008</year><volume>17</volume><issue>2</issue><fpage>130</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.ijoa.2008.01.002</pub-id><pub-id pub-id-type="pmid">18313286</pub-id></element-citation></ref><ref id="A6884R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngan Kee</surname><given-names>WD</given-names></name><name><surname>Khaw</surname><given-names>KS</given-names></name><name><surname>Ma</surname><given-names>KC</given-names></name><name><surname>Wong</surname><given-names>AS</given-names></name><name><surname>Lee</surname><given-names>BB</given-names></name><name><surname>Ng</surname><given-names>FF</given-names></name></person-group><article-title>Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial.</article-title><source>Anesthesiology.</source><year>2006</year><volume>104</volume><issue>1</issue><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1097/00000542-200601000-00004</pub-id><pub-id pub-id-type="pmid">16394684</pub-id></element-citation></ref><ref id="A6884R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>BY</given-names></name><name><surname>Jeong</surname><given-names>CW</given-names></name><name><surname>Jang</surname><given-names>EA</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Jeong</surname><given-names>ST</given-names></name><name><surname>Shin</surname><given-names>MH</given-names></name><etal>et al.</etal></person-group><article-title>Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery.</article-title><source>Br J Anaesth.</source><year>2011</year><volume>106</volume><issue>1</issue><fpage>82</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/bja/aeq275</pub-id><pub-id pub-id-type="pmid">20947593</pub-id></element-citation></ref><ref id="A6884R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imani</surname><given-names>F</given-names></name><name><surname>Entezari</surname><given-names>SR</given-names></name><name><surname>Alebouyeh</surname><given-names>MR</given-names></name><name><surname>Parhizgar</surname><given-names>S</given-names></name></person-group><article-title>The maternal and neonatal effects of adding tramadol to 2% lidocaine in epidural anesthesia for Cesarean section.</article-title><source>Anesth Pain.</source><year>2011</year><volume>1</volume><issue>1</issue><fpage>25</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5812/kowsar.22287523.1271</pub-id></element-citation></ref><ref id="A6884R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safavi</surname><given-names>M</given-names></name><name><surname>Honarmand</surname><given-names>A</given-names></name><name><surname>Azari</surname><given-names>N</given-names></name></person-group><article-title>Attenuation of the Pressor Response to Tracheal Intubation in Severe Preeclampsia: Relative Efficacies of Nitroglycerine Infusion, Sublingual Nifedipine, and Intravenous Hydralazine.</article-title><source>Anesth Pain.</source><year>2011</year><volume>1</volume><issue>2</issue><fpage>81</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5812/kowsar.22287523.1782</pub-id></element-citation></ref><ref id="A6884R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanci</surname><given-names>V</given-names></name></person-group><article-title>Tracheal Intubation Without Use of Muscle Relaxants: Comparison of Remifentanil and Alfentanil.</article-title><source>Anesth Pain.</source><year>2012</year><volume>1</volume><issue>3</issue><fpage>210</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.5812/kowsar.22287523.3599</pub-id></element-citation></ref><ref id="A6884R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imani</surname><given-names>F</given-names></name><name><surname>Alebouyeh</surname><given-names>MR</given-names></name><name><surname>Taghipour-Anvari</surname><given-names>Z</given-names></name><name><surname>Faiz</surname><given-names>SHR</given-names></name></person-group><article-title>Use of remifentanil and alfentanil in endotracheal intubation: a comparative study.</article-title><source>Anesth Pain.</source><year>2011</year><volume>1</volume><issue>2</issue><fpage>61</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.5812/kowsar.22287523.2130</pub-id></element-citation></ref><ref id="A6884R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imani</surname><given-names>F</given-names></name><name><surname>Jafarian</surname><given-names>A</given-names></name><name><surname>Hassani</surname><given-names>V</given-names></name><name><surname>Khan</surname><given-names>ZH</given-names></name></person-group><article-title>Propofol-alfentanil vs propofol-remifentanil for posterior spinal fusion including wake-up test.</article-title><source>Br J Anaesth.</source><year>2006</year><volume>96</volume><issue>5</issue><fpage>583</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1093/bja/ael075</pub-id><pub-id pub-id-type="pmid">16567343</pub-id></element-citation></ref></ref-list></back></article>